Nifty
Sensex
:
:
15778.45
52653.07
69.05 (0.44%)
209.36 (0.40%)

Pharmaceuticals & Drugs - Veterinary

Rating :
46/99

BSE: 524669 | NSE: HESTERBIO

2377.00
29-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  2345.00
  •  2422.15
  •  2328.40
  •  2328.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  7170
  •  169.01
  •  3134.00
  •  1286.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,025.06
  • 58.82
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,108.31
  • 0.42%
  • 8.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.73%
  • 3.34%
  • 31.89%
  • FII
  • DII
  • Others
  • 0.58%
  • 0.40%
  • 10.06%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.08
  • 11.73
  • 6.37

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.95
  • 10.85
  • 0.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.29
  • 7.89
  • -6.08

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.24
  • 38.35
  • 38.56

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.18
  • 7.54
  • 7.30

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.77
  • 23.17
  • 22.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
64.17
43.62
47.11%
56.89
50.69
12.23%
53.41
44.20
20.84%
39.85
44.76
-10.97%
Expenses
44.40
36.43
21.88%
35.72
29.99
19.11%
37.61
33.14
13.49%
27.95
27.19
2.80%
EBITDA
19.78
7.19
175.10%
21.18
20.70
2.32%
15.80
11.05
42.99%
11.90
17.57
-32.27%
EBIDTM
30.82%
16.48%
37.22%
40.83%
29.59%
25.01%
29.86%
39.26%
Other Income
2.48
4.79
-48.23%
1.27
0.30
323.33%
0.24
0.70
-65.71%
0.69
0.57
21.05%
Interest
1.44
2.54
-43.31%
1.52
2.63
-42.21%
2.11
1.41
49.65%
1.53
1.90
-19.47%
Depreciation
3.63
3.20
13.44%
3.27
3.42
-4.39%
3.24
3.23
0.31%
3.18
3.23
-1.55%
PBT
13.87
6.24
122.28%
17.66
14.95
18.13%
10.69
7.11
50.35%
7.88
13.02
-39.48%
Tax
3.77
1.48
154.73%
4.79
3.00
59.67%
4.01
0.91
340.66%
2.83
4.94
-42.71%
PAT
10.10
4.76
112.18%
12.87
11.95
7.70%
6.68
6.21
7.57%
5.05
8.09
-37.58%
PATM
15.74%
10.91%
22.62%
23.57%
12.51%
14.04%
12.67%
18.07%
EPS
11.39
3.22
253.73%
14.51
13.54
7.16%
7.85
7.67
2.35%
6.72
9.86
-31.85%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
-
214.33
183.27
178.07
135.94
123.11
100.89
90.64
69.05
65.10
48.26
Net Sales Growth
-
16.95%
2.92%
30.99%
10.42%
22.02%
11.31%
31.27%
6.07%
34.89%
 
Cost Of Goods Sold
-
50.23
27.98
28.47
23.31
28.45
19.75
25.32
11.39
15.42
7.75
Gross Profit
-
164.11
155.29
149.60
112.63
94.65
81.14
65.32
57.65
49.68
40.51
GP Margin
-
76.57%
84.73%
84.01%
82.85%
76.88%
80.42%
72.07%
83.49%
76.31%
83.94%
Total Expenditure
-
145.67
127.87
110.03
88.68
82.09
67.50
65.90
44.60
43.21
29.66
Power & Fuel Cost
-
7.57
8.13
7.83
6.37
5.59
5.81
4.77
4.40
3.30
2.96
% Of Sales
-
3.53%
4.44%
4.40%
4.69%
4.54%
5.76%
5.26%
6.37%
5.07%
6.13%
Employee Cost
-
38.92
40.65
28.93
23.24
18.32
15.44
12.32
9.84
9.06
6.87
% Of Sales
-
18.16%
22.18%
16.25%
17.10%
14.88%
15.30%
13.59%
14.25%
13.92%
14.24%
Manufacturing Exp.
-
11.60
11.98
11.34
9.45
7.06
7.85
5.25
5.28
4.15
4.09
% Of Sales
-
5.41%
6.54%
6.37%
6.95%
5.73%
7.78%
5.79%
7.65%
6.37%
8.47%
General & Admin Exp.
-
15.29
13.47
13.72
13.81
11.47
10.23
8.90
7.23
6.09
4.76
% Of Sales
-
7.13%
7.35%
7.70%
10.16%
9.32%
10.14%
9.82%
10.47%
9.35%
9.86%
Selling & Distn. Exp.
-
15.02
18.97
16.77
9.11
8.15
6.77
7.14
4.87
4.34
2.68
% Of Sales
-
7.01%
10.35%
9.42%
6.70%
6.62%
6.71%
7.88%
7.05%
6.67%
5.55%
Miscellaneous Exp.
-
7.06
6.69
2.98
3.40
3.05
1.64
2.20
1.58
0.84
2.68
% Of Sales
-
3.29%
3.65%
1.67%
2.50%
2.48%
1.63%
2.43%
2.29%
1.29%
1.12%
EBITDA
-
68.66
55.40
68.04
47.26
41.02
33.39
24.74
24.45
21.89
18.60
EBITDA Margin
-
32.03%
30.23%
38.21%
34.77%
33.32%
33.10%
27.29%
35.41%
33.63%
38.54%
Other Income
-
4.68
6.37
7.21
2.55
0.42
0.88
0.34
0.79
0.20
0.24
Interest
-
6.60
7.37
6.63
4.04
3.50
3.72
4.83
6.46
3.26
2.83
Depreciation
-
13.31
13.07
11.76
9.66
7.00
5.75
5.92
5.41
4.43
4.12
PBT
-
53.42
41.33
56.86
36.12
30.93
24.81
14.33
13.37
14.41
11.90
Tax
-
15.40
10.32
16.16
13.05
8.15
5.63
4.82
4.20
5.34
4.41
Tax Rate
-
30.74%
24.97%
28.42%
36.13%
26.35%
22.69%
28.39%
31.41%
37.06%
37.06%
PAT
-
34.43
29.17
41.56
25.62
23.55
19.19
12.47
9.45
9.26
7.61
PAT before Minority Interest
-
34.70
31.00
40.69
23.07
22.79
19.18
12.17
9.16
9.07
7.49
Minority Interest
-
-0.27
-1.83
0.87
2.55
0.76
0.01
0.30
0.29
0.19
0.12
PAT Margin
-
16.06%
15.92%
23.34%
18.85%
19.13%
19.02%
13.76%
13.69%
14.22%
15.77%
PAT Growth
-
18.03%
-29.81%
62.22%
8.79%
22.72%
53.89%
31.96%
2.05%
21.68%
 
EPS
-
40.51
34.32
48.89
30.14
27.71
22.58
14.67
11.12
10.89
8.95

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
228.31
201.07
177.46
140.63
121.95
101.71
84.92
75.01
67.30
59.76
Share Capital
8.51
8.51
8.51
8.51
8.51
8.51
8.51
8.51
8.51
5.67
Total Reserves
219.80
192.56
168.95
132.13
113.44
93.20
76.41
66.50
58.79
54.09
Non-Current Liabilities
113.72
96.64
69.64
44.41
48.32
41.28
37.66
20.46
16.31
6.15
Secured Loans
82.84
76.48
58.35
36.54
44.62
33.09
30.89
14.76
13.71
1.29
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.90
0.76
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
61.37
83.46
48.66
54.63
38.01
38.20
35.01
45.47
38.89
28.22
Trade Payables
28.09
20.02
8.75
7.90
7.47
5.84
4.63
4.52
5.71
4.06
Other Current Liabilities
22.52
30.44
17.15
20.26
11.04
9.30
6.35
7.41
8.84
4.21
Short Term Borrowings
3.28
32.54
22.50
25.41
18.32
21.04
20.08
29.74
16.08
12.73
Short Term Provisions
7.48
0.46
0.26
1.07
1.18
2.02
3.95
3.80
8.27
7.21
Total Liabilities
411.05
386.59
299.46
244.04
212.88
185.84
160.46
142.22
123.70
95.43
Net Block
132.76
142.54
144.82
110.22
102.62
64.63
59.60
53.82
37.73
39.39
Gross Block
228.12
226.04
215.94
170.22
152.95
108.25
97.57
86.69
65.25
62.49
Accumulated Depreciation
95.36
83.50
70.98
60.00
50.33
43.62
37.97
32.87
27.52
23.09
Non Current Assets
249.54
227.29
157.80
145.59
132.91
111.63
100.45
85.12
73.90
49.30
Capital Work in Progress
108.99
74.15
7.05
31.81
21.29
36.46
32.60
20.55
28.89
6.30
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.07
0.28
0.28
0.28
0.00
Long Term Loans & Adv.
4.98
6.74
4.34
3.48
8.52
10.47
7.97
10.47
7.00
3.60
Other Non Current Assets
2.81
3.87
1.58
0.08
0.47
0.00
0.00
0.00
0.00
0.00
Current Assets
161.51
159.31
141.66
98.45
79.97
74.20
60.00
57.10
49.80
46.12
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
62.22
63.97
50.79
39.76
33.41
33.62
29.11
35.59
31.10
27.56
Sundry Debtors
49.21
58.44
32.87
32.29
26.53
26.24
17.76
14.06
15.04
14.36
Cash & Bank
21.27
23.53
41.05
13.39
11.48
5.28
6.58
4.85
2.63
3.70
Other Current Assets
28.80
5.18
5.63
4.06
8.54
9.05
6.55
2.60
1.03
0.50
Short Term Loans & Adv.
26.24
8.19
11.32
8.95
5.06
2.49
6.55
2.60
1.03
0.50
Net Current Assets
100.14
75.84
92.99
43.82
41.95
36.00
25.00
11.63
10.91
17.90
Total Assets
411.05
386.60
299.46
244.04
212.88
185.83
160.45
142.22
123.70
95.42

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
58.05
36.77
46.71
38.02
34.80
18.85
19.76
9.39
11.54
14.16
PBT
50.10
41.33
56.86
36.12
30.93
24.81
18.20
13.37
14.41
11.90
Adjustment
22.66
20.13
17.92
13.63
10.86
9.38
7.34
11.91
7.67
6.75
Changes in Working Capital
-0.78
-13.75
-12.26
-2.31
0.11
-9.37
-0.33
-6.02
-5.04
-3.76
Cash after chg. in Working capital
71.99
47.71
62.52
47.44
41.90
24.82
25.21
19.25
17.04
14.89
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-13.94
-10.94
-15.81
-9.41
-7.06
-5.97
-5.45
-9.86
-5.50
-0.73
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
-0.04
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-38.37
-74.47
-21.73
-25.83
-30.19
-13.30
-21.21
-14.59
-22.55
-10.23
Net Fixed Assets
-0.70
-5.09
-11.03
-20.52
-15.30
-6.87
-12.04
-10.39
-20.32
-7.74
Net Investments
-3.21
-12.45
-13.74
-5.88
0.07
0.21
-5.25
-0.85
-0.28
0.00
Others
-34.46
-56.93
3.04
0.57
-14.96
-6.64
-3.92
-3.35
-1.95
-2.49
Cash from Financing Activity
-18.22
18.74
2.65
-11.08
1.83
-6.68
6.76
7.38
9.90
-1.84
Net Cash Inflow / Outflow
1.46
-18.96
27.63
1.12
6.45
-1.14
5.31
2.19
-1.12
2.10
Opening Cash & Equivalents
23.53
40.65
12.33
11.18
4.73
6.12
0.82
2.29
3.41
1.32
Closing Cash & Equivalent
21.27
23.53
40.65
12.33
11.18
4.99
6.12
4.48
2.29
3.41

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
268.38
236.36
208.61
165.32
143.35
119.56
96.86
88.18
79.11
70.25
ROA
8.70%
9.04%
14.97%
10.10%
11.43%
11.08%
8.06%
6.89%
8.28%
8.42%
ROE
16.16%
16.38%
25.59%
17.57%
20.38%
20.56%
15.46%
12.88%
14.28%
14.12%
ROCE
17.33%
16.53%
26.64%
20.20%
19.75%
18.98%
16.53%
17.78%
20.10%
20.27%
Fixed Asset Turnover
0.94
0.83
0.92
0.84
0.96
1.00
1.01
0.93
1.04
0.81
Receivable days
91.66
90.92
66.77
78.70
76.80
77.96
63.83
75.19
80.59
103.02
Inventory Days
107.45
114.27
92.80
97.89
97.55
111.14
127.14
172.29
160.79
187.67
Payable days
60.64
42.10
27.25
33.70
33.48
29.56
28.17
45.39
41.89
45.17
Cash Conversion Cycle
138.47
163.09
132.33
142.89
140.87
159.54
162.80
202.09
199.49
245.52
Total Debt/Equity
0.46
0.60
0.51
0.49
0.54
0.58
0.71
0.64
0.48
0.27
Interest Cover
8.59
6.61
9.57
9.95
9.84
7.67
4.52
3.07
5.41
5.21

News Update:


  • Hester Biosciences ties up with Gujarat government to explore production of COVID-19 vaccine
    17th May 2021, 11:43 AM

    It has already initiated discussions with Bharat Biotech in this regard

    Read More
  • Hester launches range of Herbal Veterinary Products
    24th Apr 2021, 11:21 AM

    Globally, the trend of medication is shifting from allopathy to herbal therapy in humans as well in veterinary

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.